Blocking cancer's deadliest process
This article was originally published in Scrip
Executive Summary
While cancer drugs are most commonly tested to treat metastatic disease, their greatest potential may be in preventing it. A sharper focus on understanding the biology of metastasis and a new paradigm for testing anti-metastatic agents will be needed to realise this promise, writes Malini Guha